Data Mining and clinical study of Traditional Chinese medicine in the treatment of functional constipation with qi stagnation based on real world data

注册号:

Registration number:

ITMCTR2000003618

最近更新日期:

Date of Last Refreshed on:

2020-08-21

注册时间:

Date of Registration:

2020-08-21

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

基于真实世界数据的中医药治疗气滞型功能性便秘的数据挖掘及临床研究

Public title:

Data Mining and clinical study of Traditional Chinese medicine in the treatment of functional constipation with qi stagnation based on real world data

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于真实世界数据的中医药治疗气滞型功能性便秘的数据挖掘及临床研究

Scientific title:

Data Mining and clinical study of Traditional Chinese medicine in the treatment of functional constipation with qi stagnation based on real world data

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000036166 ; ChiMCTR2000003618

申请注册联系人:

李家诚

研究负责人:

刘华

Applicant:

Jiacheng Li

Study leader:

Hua Liu

申请注册联系人电话:

Applicant telephone:

+86 15888396610

研究负责人电话:

Study leader's telephone:

+86 18930568010

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

353639894@qq.com

研究负责人电子邮件:

Study leader's E-mail:

yyliuhua@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市虹口区甘河路110号

研究负责人通讯地址:

上海市虹口区甘河路110号

Applicant address:

110 Ganhe Road, Hongkou District, Shanghai

Study leader's address:

110 Ganhe Road, Hongkou District, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海中医药大学附属岳阳中西医结合医院

Applicant's institution:

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2020-062

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

上海中医药大学附属岳阳中西医结合医院伦理委员会

Name of the ethic committee:

Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020/7/17 0:00:00

伦理委员会联系人:

殷从全

Contact Name of the ethic committee:

Congquan Yin

伦理委员会联系地址:

上海市虹口区甘河路110号

Contact Address of the ethic committee:

110 Ganhe Road, Hongkou District, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学附属岳阳中西医结合医院

Primary sponsor:

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

上海市虹口区甘河路110号

Primary sponsor's address:

110 Ganhe Road, Hongkou District, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属岳阳中西医结合医院

具体地址:

虹口区甘河路110号

Institution
hospital:

Yueyang Integrative Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine

Address:

110 Ganhe Road, Hongkou District, Shanghai

经费或物资来源:

自筹

Source(s) of funding:

Self-funded

研究疾病:

功能性便秘

研究疾病代码:

Target disease:

functional constipation

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

观察基于数据挖掘的行气导滞汤治疗气滞型功能性便秘的临床疗效评价。

Objectives of Study:

To observe the clinical efficacy evaluation of Xing Qi Dao Zhi Decoction for the treatment of functional constipation with qi stagnation based on data mining.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1.符合罗马 IV 功能性便秘诊断标准;中医辨证属于气滞型; 2.年龄≥18周岁且≤65周岁;性别不限; 3.入组前至少一周内未服用任何通便药(如:杜密克、麻仁软胶囊); 4.理解、同意参加本研究并签署知情同意书;

Inclusion criteria

1. Roman diagnostic criteria for functional constipation IV; TCM syndrome differentiation belongs to qi stagnation; 2. Aged >=18 and <= 65 years old; No gender restriction; 3. Did not take any laxative medicine (such as Dumicol and MAREN soft capsule) for at least one week before enrollment; 4. Understand and agree to participate in this study and sign the informed consent;

排除标准:

1.合并心、脑、肝、肾等重要脏器严重损害; 2.妊娠期或哺乳期; 3.经检查确诊为结直肠器质性病变; 4.伴有肠易激综合征者,以及腹部曾有手术史者; 5.有明确焦虑、抑郁症病史并且长期服用精神类药物引起的便秘。

Exclusion criteria:

1. Severe damage to heart, brain, liver, kidney and other important organs; 2. Pregnancy or lactation; 3. Colorectal organic lesions were confirmed by examination; 4. Those with irritable bowel syndrome and those with abdominal surgery history; 5. A clear history of anxiety,depression and constipation caused by long-term use of psychiatric drugs.

研究实施时间:

Study execute time:

From 2020-09-01

To      2021-06-01

征募观察对象时间:

Recruiting time:

From 2020-09-01

To      2021-06-01

干预措施:

Interventions:

组别:

1

样本量:

30

Group:

1

Sample size:

干预措施:

行气导滞汤颗粒

干预措施代码:

1

Intervention:

Granule of Xing Qi Dao Zhi decoction

Intervention code:

组别:

2

样本量:

30

Group:

2

Sample size:

干预措施:

行气导滞汤安慰剂

干预措施代码:

2

Intervention:

Placebo of Xing Qi Dao Zhi decoction

Intervention code:

样本总量 Total sample size : 60

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属岳阳中西医结合医院

单位级别:

三级甲等

Institution/hospital:

Yueyang Integrative Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

排便时间

指标类型:

次要指标

Outcome:

Defecation time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

尿素氮

指标类型:

附加指标

Outcome:

BUN

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血小板计数

指标类型:

附加指标

Outcome:

PLT

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

妊娠期妇女尿妊娠试验

指标类型:

附加指标

Outcome:

HCG

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

便秘症状评分

指标类型:

主要指标

Outcome:

Constipation symptom scores

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

排便频率

指标类型:

次要指标

Outcome:

Endless bowel movements and a sense of bulge

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

便秘症状评分

指标类型:

主要指标

Outcome:

Constipation symptom scores

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

粪便性状

指标类型:

次要指标

Outcome:

Fecal character

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

排便时间

指标类型:

次要指标

Outcome:

Defecation time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肌酐

指标类型:

附加指标

Outcome:

Cr

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

谷丙氨酸

指标类型:

附加指标

Outcome:

ALT

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

排便下坠、不尽、坠胀感

指标类型:

次要指标

Outcome:

Endless bowel movements and a sense of bulge

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

腹胀情况

指标类型:

次要指标

Outcome:

Abdominal distension situation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

红细胞计数

指标类型:

附加指标

Outcome:

RBC

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

排便频率

指标类型:

次要指标

Outcome:

Endless bowel movements and a sense of bulge

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

谷草氨酸

指标类型:

附加指标

Outcome:

AST

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中性粒细胞百分比

指标类型:

附加指标

Outcome:

NEUT%

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

白细胞计数

指标类型:

附加指标

Outcome:

WBC

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血红蛋白浓度

指标类型:

附加指标

Outcome:

HGB

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

尿酸

指标类型:

附加指标

Outcome:

UA

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

排便费力情况

指标类型:

次要指标

Outcome:

Condition of laborious defecation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

排便频率

指标类型:

次要指标

Outcome:

Endless bowel movements and a sense of bulge

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

排便时间

指标类型:

次要指标

Outcome:

Defecation time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

尿液

组织:

Sample Name:

urine

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

标本中文名:

粪便

组织:

Sample Name:

faeces

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小
Min age years
最大
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

由四川新绿色药业有限公司采用计算机随机方式的区组随机方法

Randomization Procedure (please state who generates the random number sequence and by what method):

The new green pharmaceutical Co., LTD. Of Sichuan adopted the computer random method of district group random method

盲法:

双盲

Blinding:

Double blind

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan临床试验公共管理平台, http://www.medresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan, http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Electronic Data Capture

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture

数据管理委员会:

Data Managemen Committee:

No

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above